Co-Plavix Tablets 75mg 10’s

Description

Co-Plavix Tablets 75mg 10’s

Co-Plavix Tablets 75mg 10’s is a fixed-dose combination product intended as a continuation of therapy in patients with acute coronary syndrome already initiated with separate clopidogrel and aspirin products: Unstable angina or non-ST-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischemia). Co-Plavix Tablets 75mg 10’s is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularization (surgical or PCI, with or without stent).

ST-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. In this population, Co-Plavix has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction, or stroke in medically treated patients eligible for thrombolytic therapy.

This Tablet is also used with aspirin to treat new/worsening chest pain (new heart attack, unstable angina) and to keep blood vessels open and prevent blood clots after certain procedures (such as a cardiac stent). Clopidogrel works by blocking platelets from sticking together and prevents them from forming harmful clots.

Uses

This medicine is used to treat mild to moderate pain, and prevent secondary thrombotic cerebrovascular (formation of a clot or other blockage in one of the blood vessels of the brain) or cardiovascular disease (damage to blood vessels supplying the heart) following surgery.

Side Effects Of Co-Plavix Tablets 75mg 10’s

The patients administered with this medicine may experience,

• bleeding,
• gastrointestinal disturbances,
• skin reactions,
• nervous system disturbances,
• liver-associated disorders,
• white blood cell disorders,
• and Stevens-Jhonson Syndrome (allergic reaction).

When Not To Use

The patients with active or history of,

• peptic ulcers (intestinal inflammation),
• hemophilia (bleeding disorder) and other bleeding disorders,
• severe renal (kidney) or hepatic (liver) impairment, and children under 16 years (unless prescribed by your doctor) should avoid the use of this medicine.